David Eling
David Eling is a highly accomplished professional with a strong background in Cancer, Immunology, and Immunotherapy.
He pursued his education diligently, obtaining a Ph.D. in Molecular Genetics and Biochemistry from the University of Cincinnati College of Medicine, and also completed a Postdoctoral position in Cancer, Immunology, and Immunotherapy at the University of California, San Diego.
David has held key roles in various prestigious organizations, showcasing his expertise and leadership. Currently, he serves as the Director of Business Development at ProSci Incorporated.
Prior to his current role, David gained valuable experience as Business Development at HTG Molecular, Territory Manager So Cal at Thermo Fisher Scientific, Scientist at Pharmingen-BD, and Project Scientist at the University of California, San Diego.
